Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
WC2031 vs Vibramycin for Uncomplicated Urogenital Chlamydia Trachomatis Infection
NCT01113931Phase 3Completed
- Sponsor
- Warner Chilcott
- Start
- Apr 2010
- Primary completion
- Oct 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of doxycycline in Chlamydia trachomatis infection (2 arms), sponsored by Warner Chilcott. Primary endpoint: Microbiological Cure Rate at Day 28. Started Apr 2010; status: completed.
02
Drugs
doxycycline
03
Conditions
Chlamydia trachomatis infection
Beyond the preview
Go deeper on NCT01113931.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01113931.